Coramaze Technologies

Private

BonnHealthcare & Life Scienceshttps://tripairtechnology.com/

Last Round

Grant

Mar 17, 2026

Total Funding Raised

$6.51M

Company Overview

Coramaze Technologies is a medical technology company that develops Tripair, a minimally invasive transcatheter solution for treating tricuspid regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicetranscatheter heart valvetricuspid regurgitationstructural heartminimally invasiveinterventional cardiologyheart implanttransfemoral accessheart valve repairmedtechstructural heart interventioncardiovascular devicevalve repair system

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coramaze Technologies Comparables

Compare Coramaze Technologies with similar companies based on industry and business-model similarity.

Coramaze Technologies comparables — related companies by embedding similarity
Company	Similarity	Market Cap
CroíValve	92%
TriFlo Cardiovascular Inc.	87%
Trisol Medical	86%

View all Comparables

Coramaze Technologies Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Mar 17, 2026
Series A	Sep 1, 2015
Seed	Feb 12, 2014

View all Funding Rounds

Key People

Founding team and executive leadership

Jochen Reinöhl

Chief Executive Officer

Executive Team

Coramaze Technologies Investors

Notable investors and investment history

Coramaze Technologies investors
Investor	Rounds
European Innovation Council Fund	Grant
SeedCapital Dortmund	Series A, Seed
High-Tech Gründerfonds	Series A, Seed
Elron Ventures	Series A

View all Investors

Coramaze Technologies Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Coramaze Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Coramaze Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersBonn

Employee Range23

Year Founded2013

Last FundingMar 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.